SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-05-008979
Filing Date
2005-07-27
Accepted
2005-07-27 16:44:05
Documents
4
Period of Report
2005-07-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y11061e8vk.htm 8-K 29449
2 EX-4.1: INDENTURE y11061exv4w1.htm EX-4.1 521886
3 EX-4.2: REGISTRATION RIGHTS AGREEMENT y11061exv4w2.htm EX-4.2 107743
4 EX-99.1: CREDIT AGREEMENT y11061exv99w1.htm EX-99.1 512289
  Complete submission text file 0000950123-05-008979.txt   1173135
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Filer) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-09114 | Film No.: 05977793
SIC: 2834 Pharmaceutical Preparations